TNF Antagonists Immunogenicity and Dose Escalation Effect on Antidrug Antibodies and Serum Drug Concentrations in IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease
Inflamm. Bowel Dis. 2021 Sep 01;27(9)1443-1451, R Battat, D Lukin, EJ Scherl, S Pola, A Kumar, L Okada, L Yang, A Jain, CA SiegelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.